Literature DB >> 20125129

Hyperplastic polyposis syndrome is associated with cigarette smoking, which may be a modifiable risk factor.

R Griff Walker1, Juergen K Landmann, David G Hewett, Daniel L Worthley, Ron L Buttenshaw, Ngaire Knight, Penny M Webb, David C Whiteman, Vicki L Whitehall, Barbara A Leggett.   

Abstract

OBJECTIVES: Hyperplastic polyposis syndrome (HPS) confers an increased risk of colorectal cancer and is difficult to manage clinically. Because both polyps and resultant cancers display the CpG island methylator phenotype and mutation of the BRAF oncogene, and because sporadic cancers with these characteristics are associated with cigarette smoking, we hypothesized that cigarette smoking may predispose to the development of HPS.
METHODS: This was a case-control study with two independent control series conducted at a tertiary hospital in Brisbane, Queensland, Australia. Cases comprised patients with HPS (n=32) recruited through the database of the Queensland Familial Bowel Registry, who satisfied the World Health Organization international classification for HPS. Cases were compared with colonoscopy controls (n=298) defined as consecutive patients undergoing colonoscopy for clinical indications, who were free from polyps. We also compared cases with a second set of population controls (n=645) selected at random from a population register serving the catchment area for cases. This was an observational study, and all participants completed a questionnaire to obtain a comprehensive smoking history.
RESULTS: The prevalence rate of current smoking was 47% in HPS patients, 17% in colonoscopy controls, and 12% in population controls. HPS patients were significantly more likely to be current smokers than were either colonoscopy controls (odds ratio (OR)=8.3, 95% confidence interval (CI): 3.0-22.9) or population controls (OR=12.7, 95% CI: 4.9-33.1).
CONCLUSIONS: Cigarette smoking is strongly associated with HPS, thus suggesting that smoking exposure may increase the expression of this condition. Further studies should examine the possible benefits of quitting smoking in HPS patients.

Entities:  

Mesh:

Year:  2010        PMID: 20125129     DOI: 10.1038/ajg.2009.757

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

Review 1.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

2.  Feasibility of Large-Scale Identification of Sessile Serrated Polyp Patients Using Electronic Records: A Utah Study.

Authors:  Kajsa Affolter; Keith Gligorich; Niloy Jewel Samadder; Wade S Samowitz; Karen Curtin
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

3.  Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps.

Authors:  James R Davenport; Timothy Su; Zhiguo Zhao; Helen G Coleman; Walter E Smalley; Reid M Ness; Wei Zheng; Martha J Shrubsole
Journal:  Gut       Date:  2016-11-15       Impact factor: 23.059

Review 4.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Type 1 serrated polyposis represents a predominantly female disease with a high prevalence of dysplastic serrated adenomas, without germline mutation in MUTYH, APC, and PTEN genes.

Authors:  Marco Petronio; Stephane Pinson; Thomas Walter; Marie-Odile Joly; Valerie Hervieu; Julien Forestier; Jean-Christophe Saurin
Journal:  United European Gastroenterol J       Date:  2015-07-24       Impact factor: 4.623

6.  Prevalence of serrated polyposis syndrome and its association with synchronous advanced adenoma and lifestyle.

Authors:  Naoya Toyoshima; Taku Sakamoto; Makomo Makazu; Takeshi Nakajima; Takahisa Matsuda; Ryoji Kushima; Tadakazu Shimoda; Takahiro Fujii; Haruhiro Inoue; Shin-Ei Kudo; Yutaka Saito
Journal:  Mol Clin Oncol       Date:  2014-09-22

Review 7.  Serrated polyposis syndrome: molecular, pathological and clinical aspects.

Authors:  Carla Guarinos; Cristina Sánchez-Fortún; María Rodríguez-Soler; Cristina Alenda; Artemio Payá; Rodrigo Jover
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

8.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.

Authors:  Daniel D Buchanan; Kevin Sweet; Musa Drini; Mark A Jenkins; Aung Ko Win; Dallas R English; Michael D Walsh; Mark Clendenning; Diane M McKeone; Rhiannon J Walters; Aedan Roberts; Sally-Ann Pearson; Erika Pavluk; John L Hopper; Michael R Gattas; Jack Goldblatt; Jill George; Graeme K Suthers; Kerry D Phillips; Sonja Woodall; Julie Arnold; Kathy Tucker; Amanda Muir; Michael Field; Sian Greening; Steven Gallinger; Renee Perrier; John A Baron; John D Potter; Robert Haile; Wendy Frankel; Albert de la Chapelle; Finlay Macrae; Christophe Rosty; Neal I Walker; Susan Parry; Joanne P Young
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

9.  Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort.

Authors:  Kory W Jasperson; Priyanka Kanth; Anne C Kirchhoff; Darcy Huismann; Amanda Gammon; Wendy Kohlmann; Randall W Burt; N Jewel Samadder
Journal:  Dis Colon Rectum       Date:  2013-11       Impact factor: 4.585

10.  Ulcerative Colitis With Concomitant Serrated Polyposis Syndrome: A Case Report and Literature Review.

Authors:  Mahmoud M Mansour; Zachary D Smith; Yezaz Ghouri; Veysel Tahan
Journal:  Cureus       Date:  2021-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.